Preview

Meditsinskiy sovet = Medical Council

Advanced search

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

https://doi.org/10.21518/2079-701X-2017-12-33-35

Abstract

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Society of Hypertension, ESH, and the European Society of Cardiology, ESC. Thus, patients with 2–3 degree increase blood pressure (BP) and high or very high added risk often do not get the combination therapy that is required for them in this clinical environment. According to the recommendations of the ESH and ESC patients with hypertension of low/medium risk of development of cardiovascular complications (CVC) and death from them a monotherapy can be prescribed if targeted AP values are achieved [1]. Patients with high or very high risk of CCO and/or AG of Degree 2 and 3 immediately must be prescribed a combination of the two drugs. If the target blood pressure values are not attained, either a combination of two drugs at the maximum therapeutic doses, or replacement of the combination of drugs is prescribed or the 3d, 4th and so on antihypertensive drug is added [2, 3]. Combination therapy may also be administered to patients with hypertension with low/medium risk of development of CVC if the target AP are not reached [3, 4].


About the Authors

N. A. Morina
Sechenov First Moscow State Medical University
Russian Federation


O. D. Savkova
Sechenov First Moscow State Medical University
Russian Federation


E. A. Fedorova
Sechenov First Moscow State Medical University
Russian Federation


I. L. Tsarev
Sechenov First Moscow State Medical University
Russian Federation


A. B. Frolkova
Sechenov First Moscow State Medical University
Russian Federation


A. E. Tsygankova
Sechenov First Moscow State Medical University
Russian Federation


A. A. Sokolova
Sechenov First Moscow State Medical University
Russian Federation

PhD in medicine



D. A. Napalkov
Sechenov First Moscow State Medical University
Russian Federation
PhD in medicine, Prof.


V. V. Fomin
Sechenov First Moscow State Medical University
Russian Federation

corresponding member of RAS, MD, Prof.



References

1. 2013 European society of hypertension/ European society of cardiology Guidelines for the management of arterial hypertension.

2. Алгоритмы ведения пациента с артериальной гипертензией. Общероссийская общественная организация содействия профилактике и лечению артериальной гипертензии «Антигипертензивная лига». СПб., 2015: 5-54.

3. Диагностика и лечение артериальной гипертонии. Клинические рекомендации. Кардиологический вестник, 2015, 1(X): 3-30.

4. Карпов Ю.А. Комбинированная антигипертензивная терапия – приоритетное направление в лечении артериальной гипертонии. РМЖ, 2011, 26: 1568-1571.

5. Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии, 2010, 3: 5-26.

6. Соколов А.В., Садыкова В.З., Решетько О.В. Анализ врачебных назначений антигипертензивной терапии при выписке из стационара больным с метаболическим синдромом. Современная медицина: актуальные вопросы, 2015, 38-39: 113-118.


Review

For citations:


Morina NA, Savkova OD, Fedorova EA, Tsarev IL, Frolkova AB, Tsygankova AE, Sokolova AA, Napalkov DA, Fomin VV. PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL. Meditsinskiy sovet = Medical Council. 2017;(12):33-35. (In Russ.) https://doi.org/10.21518/2079-701X-2017-12-33-35

Views: 615


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)